Revolution Medicines (RVMD) USD0.0001
0.09%- This stock can be held in a
Stocks and Shares ISASell:$36.54
Buy:$36.63
Change:
$0.09
(0.23%)
$0.09
(0.23%)Prices delayed by at least 15 minutes
Sell:$36.54
Buy:$36.63
Change:$0.09
(0.23%)
$0.09
(0.23%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 20 June 2025 | Jeff CisliniCompany Secretary | Sell Option/Award related | 1,912 | $39.61 | $75,735.85 | 54,093 |
| 16 June 2025 | Mark A GoldsmithChairman/CEO | Sell Tax related | 13,496 | $39.83 | $537,545.68 | 428,720 |
| 16 June 2025 | Stephen Michael KelseyOther President | Sell Tax related | 4,289 | $39.83 | $170,830.87 | 289,414 |
| 16 June 2025 | Margaret A (Peg) HornCOO | Sell Tax related | 3,510 | $39.83 | $139,803.30 | 150,675 |
| 16 June 2025 | Jack Lee AndersCFO | Sell Tax related | 2,170 | $39.83 | $86,431.10 | 113,314 |
| 16 June 2025 | Lin WeiChief Level Officer | Sell Tax related | 2,173 | $39.83 | $86,550.59 | 90,499 |
| 16 June 2025 | Jeff CisliniCompany Secretary | Sell Tax related | 1,878 | $39.83 | $74,800.74 | 56,005 |
| 20 March 2025 | Jeff CisliniCompany Secretary | Sell Option/Award related | 2,041 | $38.71 | $79,008.13 | 57,723 |
| 17 March 2025 | Mark A GoldsmithChairman/CEO | Sell Tax related | 11,738 | $39.04 | $458,255.04 | 441,564 |
| 17 March 2025 | Stephen Michael KelseyOther President | Sell Tax related | 3,294 | $39.04 | $128,598.75 | 293,051 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 5 December 2024 | NEXTECH INVEST AGVenture Capital | Buy Regular purchase transaction | 760,869 | $46.00 | $34,999,974.00 | 760,869 |
| 5 December 2024 | NEXTECH INVEST AGVenture Capital | Buy Regular purchase transaction | 543,478 | $46.00 | $24,999,988.00 | 2,096,612 |
| 4 November 2024 | Mark A GoldsmithChairman/CEO | Sell Option/Award related | 50,900 | $55.56 | $2,827,820.76 | 300,170 |
| 11 October 2024 | Margaret A (Peg) HornCOO | Sell Option/Award related | 50,000 | $50.34 | $2,517,055.00 | 132,320 |
| 11 October 2024 | Mark A GoldsmithChairman/CEO | Sell Option/Award related | 30,000 | $50.36 | $1,510,773.00 | 300,170 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.